IVDs retain central role in progress of UK diabetes programme
This article was originally published in Clinica
Executive Summary
The UK's in vitro diagnostics (IVDs) industry has welcomed the progress in delivering the national service framework (NSF) for diabetes during the last five years, citing the ongoing input of its technology in supporting screening and monitoring targets.